Skip to main content
NewslettersWatchlist

Bio-Rad Laboratories(BIO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low325.88
Day High343.60
Open:343.60
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.
Barchart
Stocks Finish Higher on Support From Chip Stock Rebound
The Globe and Mail
Market movers: Stocks seeing action on Monday - and why
Barchart
Stocks Close in the Red, Nvidia Trades Lower After Earnings Report
Barchart
Broader Market Lower as Chip Stocks Tumble
TheNewswire.com
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Newswire.ca
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
BayStreet.ca
Biotech's Developments in Race Against Rising Cancer Rates Revealed
Barchart
Stocks Waver on Higher Bond Yields Ahead of Fed Chair Powell
Barchart
Stocks Finish Lower as Sticky Price Pressures Dampen Rate Cut Hopes
Barchart
Stocks Fall and Bond Yields Climb as Strong U.S. PPI Curbs Rate Cut Hopes
Barchart
Stocks Finish Mixed as a Slump in Intel Weighs on the Overall Market
Barchart
Broader Market Gains on Goldilocks U.S. Economy
Barchart
Stocks Post Modest Gains on Hopes for a Fed Pause
Barchart
Stocks Settle Mixed on Weakness in Tech
The Globe and Mail
Bio-Rad Laboratories: Top 25 Undervalued S&P 500 Composite Index Stocks (BIO)
Business Wire
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
Barchart
A Surge in Regional Banks and Strong Apple Earnings Boost Stocks
Barchart
Stocks Jump as Bank Stock Rebound and Apple Soars
Business Wire
Bio-Rad Reports First-Quarter 2023 Financial Results
Business Wire
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
Business Wire
Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer

Profile

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.